Keyphrases
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Primary Diffuse Large B-cell Lymphoma
100%
Primary Central Nervous System Lymphoma (PCNSL)
60%
Endometrial Cancer
40%
BCL6
40%
Immunohistochemistry
40%
Immunoglobulin Heavy Chain
40%
Neoplastic Cells
40%
Common Origin
40%
Clinical Relapse
40%
Older Women
20%
Lymphoma
20%
Headache
20%
Chemotherapy
20%
Non-Hodgkin Lymphoma
20%
Poor Outcome
20%
Methotrexate
20%
Dizziness
20%
Central Nervous System Tumors
20%
B-lineage
20%
Immunoglobulin
20%
Flow Cytometric Analysis
20%
Brain Biopsy
20%
Growth Pattern
20%
Neoplasms
20%
Fluorescence in Situ Hybridization
20%
Suspicious for Malignancy
20%
Splenium of Corpus Callosum
20%
Initial Diagnosis
20%
Molecular Genetic Testing
20%
Extracranial
20%
Histological Examination
20%
Enhanced Magnetic Resonance Imaging
20%
Rare Forms
20%
Brain Lesions
20%
Clinical Remission
20%
Final Diagnosis
20%
Primary Lesion
20%
Diffusion-controlled Growth
20%
Patient Concerns
20%
Adrenal Mass
20%
Large B-cell Lymphoma
20%
Adrenal Lesions
20%
Kappa Analysis
20%
Radiological Study
20%
Whole Brain Radiotherapy
20%
Secondary Lesions
20%
Medicine and Dentistry
Central Nervous System
100%
Diffuse Large B-Cell Lymphoma
100%
Primary Central Nervous System Lymphoma
50%
B-Cell Lymphoma
33%
Immunohistochemistry
33%
Uterine Cancer
33%
Immunoglobulin Heavy Chain
33%
Morphology
16%
B Cell
16%
Magnetic Resonance Imaging
16%
Neoplasm
16%
Cancer
16%
Non-Hodgkin Lymphoma
16%
Fluorescence in Situ Hybridization
16%
Brain Biopsy
16%
Cell Lineage
16%
Corpus Callosum
16%
Headache
16%
Final Diagnosis
16%
Dizziness
16%
Large-Cell Lymphoma
16%
Whole Brain Radiotherapy
16%
Splenium
16%
Immunoglobulin Kappa Chain
16%
Methotrexate
16%